Cefcapene: Difference between revisions
Created page with "<div style="float: right;"> thumb|none|400px|This image is provided by the National Library of Medicine.</div> __NOTOC__ {{SI}} {{CMG}} ==Overview==..." |
No edit summary |
||
Line 1: | Line 1: | ||
<div style="float: right;"> | <div style="float: right;"> | ||
[[File:Cefcapene.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div> | [[File:Cefcapene.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div> | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
'''Cefcapene''' ([[International Nonproprietary Name|INN]]) is a third-generation [[cephalosporin]] [[antibiotic]]. | '''Cefcapene''' ([[International Nonproprietary Name|INN]]) is a third-generation [[cephalosporin]] [[antibiotic]]. | ||
==References== | |||
{{reflist|2}} | |||
{{CephalosporinAntiBiotics}} | {{CephalosporinAntiBiotics}} | ||
[[Category:Cephalosporin antibiotics]] | [[Category:Cephalosporin antibiotics]] | ||
[[Category:Thiazoles]] | [[Category:Thiazoles]] | ||
[[Category:Drug]] | [[Category:Drug]] | ||
Revision as of 14:32, 7 April 2015
WikiDoc Resources for Cefcapene |
Articles |
---|
Most recent articles on Cefcapene |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cefcapene at Clinical Trials.gov Clinical Trials on Cefcapene at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cefcapene
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Cefcapene Discussion groups on Cefcapene Directions to Hospitals Treating Cefcapene Risk calculators and risk factors for Cefcapene
|
Healthcare Provider Resources |
Causes & Risk Factors for Cefcapene |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cefcapene (INN) is a third-generation cephalosporin antibiotic.
References